- 2024-08-20 01:58抑制剂Indeglitazar|Indeglitazar|835619-41-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂IMB-XH1|IMB-XH1|292057-76-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂INCB-057643|INCB-057643|1820889-23-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂INCB086550|INCB086550|2230911-59-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:58抑制剂INCB086550|INCB086550|2230911-59-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂Imaradenant|Imaradenant|1321514-06-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂IMB-XH1|IMB-XH1|292057-76-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:58抑制剂IMB-XH1|IMB-XH1|292057-76-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂IM-54|IM-54|861891-50-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂IM-54|IM-54|861891-50-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂Imaradenant|Imaradenant|1321514-06-0|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:58抑制剂Imaradenant|Imaradenant|1321514-06-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂iKIX1|iKIX1|656222-54-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:58抑制剂iKIX1|iKIX1|656222-54-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂iKIX1|iKIX1|656222-54-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂IM-54|IM-54|861891-50-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:58抑制剂IDO5L|IDO5L|914471-09-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:58抑制剂IDO5L|IDO5L|914471-09-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂IDO5L|IDO5L|914471-09-3|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 01:58抑制剂IDO1-IN-5|IDO1-IN-5|2166616-75-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
